MwanzoRDY • NYSE
Dr Reddy's Laboratories Ltd
$ 13.65
Baada ya Saa za Kazi:
$ 13.65
(0.00%)0.00
Imefungwa: 27 Jan, 16:00:55 GMT -5 · USD · NYSE · Kanusho
Hisa zinazouzwa MarekaniMakao yake makuu ni IN
Bei iliyotangulia
$ 14.01
Bei za siku
$ 13.59 - $ 13.78
Bei za mwaka
$ 13.59 - $ 16.89
Thamani ya kampuni katika soko
11.50B USD
Wastani wa hisa zilizouzwa
1.90M
Alama ya CDP ya Tabia Nchi
A-
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(INR)Des 2024Mabadiliko Tangu Mwaka Uliopita
Mapato
83.59B15.85%
Matumizi ya uendeshaji wa biashara
30.34B19.95%
Mapato halisi
14.13B2.49%
Kiwango cha faida halisi
16.91-11.51%
Mapato kwa kila hisa
16.941.81%
EBITDA
23.43B13.31%
Asilimia ya kodi ya mapato
25.10%
Jumla ya mali
Jumla ya dhima
(INR)Des 2024Mabadiliko Tangu Mwaka Uliopita
Uwekezaji wa pesa taslimu na vipindi vifupi
59.92B-17.41%
Jumla ya mali
481.06B29.02%
Jumla ya dhima
159.49B51.91%
Jumla ya hisa
321.56B
hisa zilizosalia
833.12M
Uwiano wa bei na thamani
0.04
Faida inayotokana na mali
9.88%
Faida inayotokana mtaji
12.81%
Mabadiliko halisi ya pesa taslimu
(INR)Des 2024Mabadiliko Tangu Mwaka Uliopita
Mapato halisi
14.13B2.49%
Pesa kutokana na shughuli
6.62B39.75%
Pesa kutokana na uwekezaji
-5.46B66.27%
Pesa kutokana na ufadhili
590.00M-88.83%
Mabadiliko halisi ya pesa taslimu
1.75B129.12%
Mtiririko huru wa pesa
-382.75M90.46%
Kuhusu
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. By 2007, Dr. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1984
Wafanyakazi
27,048
Gundua zaidi
Huenda unavutiwa na
Orodha hii imetokana na maudhui uliyotafuta hivi majuzi, hisa unazofuatilia na shughuli zingine. Pata maelezo zaidi

Data na maelezo yote hutolewa “kama yalivyo” kwa madhumuni ya taarifa binafsi tu, wala hayanuii kuwa ushauri wa kifedha na hayana madhumuni ya kufanya biashara au uwekezaji, kodi, kisheria, uhasibu au ushauri mwingine. Google si mshauri wa uwekezaji wala mshauri wa kifedha na haitoi maoni au mapendekezo yanayohusiana na kampuni zozote zilizojumuishwa kwenye orodha hii au hisa zozote zilizotolewa na kampuni hizo. Tafadhali wasiliana na dalali wako au mwakilishi wa kifedha ili uthibitishe bei kabla ya kufanya biashara yoyote. Pata maelezo zaidi
Watu pia hutafuta
Tafuta
Futa utafutaji
Funga kisanduku cha kutafutia
Programu za Google
Menyu kuu